Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biological potency comparison of native, depigmented, and depigmented-polymerized cat epithelium allergen extracts
2012-001931-30Phase 2Active
- Sponsor
- LETI Pharma
- Start
- Jul 2012
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of depigmented cat epithelial allergenic extract in cat allergy (3 arms), sponsored by LETI Pharma. Started Jul 2012; status: active.
02
Drugs
depigmented cat epithelial allergenic extract
03
Conditions
cat allergy
Beyond the preview
Go deeper on 2012-001931-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-001931-30.